Remove topic chemical-synthesis-small-molecule
article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. They do not address the underlying issue responsible for global warming, namely that almost all organic chemicals including plastics originate from fossil resources.

article thumbnail

CHARM Therapeutics secures funding for oncology drug discovery research

Pharmaceutical Technology

“With this investment and continued use of NVIDIA’s advanced computing technology, we believe we can accelerate the development of our small molecule therapies, bringing them to patients faster and more efficiently than ever before.” Topic sponsors are not involved in the creation of editorial content.

Medicine 103
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Teijin Pharma and Novartis sign licence deal for kidney disease candidate

Pharmaceutical Technology

Teijin Pharma and Novartis have signed an exclusive global licence agreement for an investigational preclinical small molecule candidate for proteinuric kidney diseases. The company discovered the new investigational small molecule candidate at a drug development base in Tokyo, the Teijin Institute for Biomedical Research.

Pharma 105
article thumbnail

Gilead and Arcus Biosciences expand research collaboration for inflammatory diseases

Pharmaceutical Technology

Arcus CEO Terry Rosen stated: “Through this expansion of our partnership with Gilead, we can combine our research expertise in immunology and small molecule drug discovery with Gilead’s strong clinical experience in inflammation. Topic sponsors are not involved in the creation of editorial content.

Medical 52
article thumbnail

Sunshine Biopharma signs licence deal for Covid-19 treatment

Pharmaceutical Technology

The licensed technology specifically includes small molecules found to be efficient PLpro inhibitors. Topic sponsors are not involved in the creation of editorial content. These sets of chemically synthesized individual peptides are made on a small scale using Mimotopes’ unique proprietary parallel array synthesis platform.

article thumbnail

Cholesgen and AstraZeneca to advance research in hypercholesterolemia

Pharmaceutical Technology

The companies will validate genetic drug targets and advance therapeutic molecules into clinical development. Topic sponsors are not involved in the creation of editorial content. These sets of chemically synthesized individual peptides are made on a small scale using Mimotopes’ unique proprietary parallel array synthesis platform.

article thumbnail

Confo and Lilly sign licence deal peripheral pain candidate

Pharmaceutical Technology

“CFTX-1554’s progression through the clinic will benefit from Lilly’s experience and global organisation while we continue to develop and expand our growing, innovative pipeline of GPCR-targeted assets, both small molecules and biologics.” Topic sponsors are not involved in the creation of editorial content.